Steinberg Global Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$205K Buy
+2,177
New +$190K 0.03% 250
2018
Q4
Sell
-10,932
Closed -$978K 258
2018
Q3
$978K Sell
10,932
-292
-3% -$25.8K 0.14% 133
2018
Q2
$891K Sell
11,224
-684
-6% -$56.8K 0.13% 133
2018
Q1
$1.06M Sell
11,908
-672
-5% -$64.5K 0.16% 117
2017
Q4
$1.31M Buy
12,580
+1,967
+19% +$222K 0.19% 103
2017
Q3
$1.55M Buy
10,613
+3,939
+59% +$537K 0.23% 94
2017
Q2
$867K Buy
6,674
+80
+1% +$9.8K 0.13% 128
2017
Q1
$820K Buy
6,594
+39
+0.6% +$4.67K 0.13% 130
2016
Q4
$759K Buy
6,555
+23
+0.4% +$2.56K 0.13% 128
2016
Q3
$683K Sell
6,532
-397
-6% -$43K 0.11% 128
2016
Q2
$683K Sell
6,929
-402
-5% -$41.6K 0.12% 123
2016
Q1
$734K Buy
+7,331
New +$755K 0.14% 111

Other funds holding CELG

Steinberg Global Asset Management's CELG Position: Q1 2019 in Review

Steinberg Global Asset Management opened a new position in Celgene Corp (CELG) in Q1 2019: 2,177 shares worth $205K. The stake represents 0.03% of the portfolio and ranks #250 among its holdings. This is a return to the name: Steinberg Global Asset Management previously reported a position in CELG as recently as Q3 2018.

Steinberg Global Asset Management first reported a position in CELG in Q1 2016 and has held it in 12 quarters since. The position peaked at $1.55M in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Steinberg Global Asset Management held 2,177 shares of Celgene Corp worth $205K as of Q1 2019.
  • Celgene Corp was a new Steinberg Global Asset Management position in Q1 2019.
  • Celgene Corp made up 0.03% of Steinberg Global Asset Management's portfolio in Q1 2019, its #250 holding.
  • Steinberg Global Asset Management first reported a position in Celgene Corp in Q1 2016 and has held it in 12 quarters since.
  • Steinberg Global Asset Management's Celgene Corp position peaked at $1.55M in Q3 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Steinberg Global Asset Management's 13F filing for Q1 2019, filed 15 Apr 2019.